New Diabetes Treatment Now Available in Tunisia, Marking a Significant Breakthrough in Disease Management
Innovative Treatment Launched on May 2, 2026, Offers a Novel Weekly Injection Regimen
A groundbreaking new medication for the treatment of diabetes is now available in Tunisia, marking a notable advancement in the management of this condition. The innovative treatment was launched on Saturday, May 2, 2026, and is distinguished by its unique administration method, which involves a single weekly injection.
Public Access Begins on May 6, 2026
According to Dr. Leïla Obeid, head of the cardiology department at Sfax's Hédi Chaker Hospital, the medication will be available to the general public in Tunisian pharmacies starting this Wednesday, May 6, 2026.
Benefits Extend Beyond Diabetes Management
Dr. Obeid highlights that this treatment offers additional benefits, including weight loss, as approximately 80% of individuals with diabetes suffer from obesity or overweight. The specialist also notes that the medication contributes to the prevention of cardiovascular and cerebral accidents, while supporting cardiac and renal functions.
Important Notes on Treatment Usage
While Dr. Obeid emphasizes that this treatment does not replace insulin, it can help delay its use. She also stresses the importance of consulting a doctor before using the medication.
Translation Notes:
- The original article's title and subheadings were maintained to preserve the original structure and emphasis.
- The text was reformatted to adhere to Markdown conventions.
- The translation aimed to preserve the original meaning, tone, and style while ensuring clarity and accuracy in the English version.
